Regulatory

Regulatory  ·  Weekly Digest - 21 February to 27 February 2026
Aktis Oncology receives U.S. FDA Fast Track Designation for AKY-1189, a nectin-4 miniprotein radioconjugate

Weekly Digest – February 2026 Weekly Digest – February 2026 24 February 2026: Aktis Oncology receives U.S. FDA Fast Track Designation for AKY-1189, a nectin-4 miniprotein radioconjugate Aktis Oncology announced that the U.S. FDA has granted Fast Track designation to […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 21 February to 27 February 2026
Kivu Bioscience announced HREC approval and Clinical Trial Notification (CTN) clearance in Australia to initiate a first-in-human clinical trial for KIVU-305

Weekly Digest – February 2026 Weekly Digest – February 2026 25 February 2026: Kivu Bioscience announced HREC approval and Clinical Trial Notification (CTN) clearance in Australia to initiate a first-in-human clinical trial for KIVU-305 Kivu Bioscience announced new preclinical data […]

by Sandhya Ramalingam

Continue Reading